RhumbLine Advisers’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

RhumbLine Advisers’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-233,549	Closed	-$591K	–	4304
2023 Q4	$591K	Sell	233,549 -2,730	-1%	-$6.36K	﹤0.01%	2569
2023 Q3	$565K	Buy	236,279 +5,021	+2%	+$11.1K	﹤0.01%	2550
2023 Q2	$534K	Sell	231,258 -7,027	-3%	-$19.8K	﹤0.01%	2646
2023 Q1	$608K	Buy	238,285 +14,370	+6%	+$41.2K	﹤0.01%	2358
2022 Q4	$562K	Buy	223,915 +4,513	+2%	+$12.6K	﹤0.01%	2411
2022 Q3	$636K	Buy	219,402 +12,608	+6%	+$53.1K	﹤0.01%	2383
2022 Q2	$935K	Buy	+206,794	New	+$1.23M	﹤0.01%	2172

RhumbLine Advisers's SLGC Position: Q1 2024 in Review

RhumbLine Advisers sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 233,549 shares — an estimated $591K sold.

RhumbLine Advisers first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $935K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

RhumbLine Advisers reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
RhumbLine Advisers sold 233,549 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $591K.
RhumbLine Advisers first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
RhumbLine Advisers's SomaLogic, Inc. Class A Common Stock position peaked at $935K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.